Milan - Delayed Quote EUR
Bayer Aktiengesellschaft (1BAYN.MI)
26.03
+1.98
+(8.23%)
As of 11:55:16 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 1 | 1 | 15 | 17 |
Avg. Estimate | 10.29B | 9.74B | 46.05B | 46.86B |
Low Estimate | 10.29B | 9.74B | 44.56B | 44.91B |
High Estimate | 10.29B | 9.74B | 46.9B | 48.87B |
Year Ago Sales | 11.14B | 9.97B | 46.61B | 46.05B |
Sales Growth (year/est) | -7.67% | -2.26% | -1.20% | 1.77% |
EPS Trend
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
1BAYN.MI | -- | -- | -- | -- |
S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Related Tickers
1PFE.MI Pfizer Inc.
20.76
+0.73%
RCDTF Recordati Industria Chimica e Farmaceutica S.p.A.
49.00
-10.91%
SZD.F Santen Pharmaceutical Co., Ltd.
8.45
0.00%
1ABBV.MI AbbVie Inc.
171.00
-0.70%
1LLY.MI Eli Lilly and Company
682.50
+1.04%
IDP.SG Biogen Inc
111.05
+7.76%
1JNJ.MI JOHNSON & JOHNSON
139.08
-0.20%
RHO.HM Roche Holding AG
294.20
+3.59%
NOVNEE.SW Novartis AG
91.68
+0.74%
GILD.VI Gilead Sciences, Inc.
93.73
+1.36%